Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network

被引：4
|
作者：
Ghesquieres, Herve [1 ]
Houillier, Caroline [2 ,3 ]
Chinot, Olivier [4 ]
Choquet, Sylvain [3 ,5 ]
Molucon-Chabrot, Cecile [6 ]
Beauchene, Patrick [7 ]
Gressin, Remy [8 ]
Morschhauser, Franck [9 ]
Schmitt, Anna [10 ]
Gyan, Emmanuel [11 ]
Hoang-Xuan, Khe [2 ,3 ]
Nicolas-Virelizier, Emmanuelle [12 ]
Chevrier, Marion [13 ]
Savignoni, Alexia [13 ]
Turbiez, Isabelle [14 ]
Veillas, Florence [15 ]
Soumelis, Vassili [16 ,17 ]
Soussain, Carole [18 ]
机构：
[1] Univ Claude Bernard, Hospices Civils Lyon, Ctr Hospitalier Lyon Sud, Pierre Benite, France
[2] Hop La Pitie Salpetriere, Neuro Oncol Dept, Paris, France
[3] Pierre & Marie Curie Univ, Paris, France
[4] Hop La Timone, Neuro Oncol, Marseille, France
[5] Hop La Pitie Salpetriere, Dept Clin Hematol, Paris, France
[6] CHU Clermont Ferrand, Dept Hematol, Clermont Ferrand, France
[7] CHU Nancy, Neuro Oncol, Nancy, France
[8] CHU Grenoble, Hematol, Grenoble, France
[9] Univ Lille, Dept Clin Hematol, Ctr Hospitalier Univ, Lille, France
[10] Inst Bergonie, Dept Hematol, Bordeaux, France
[11] Ctr Hospitalier Univ, Serv Hematol & Therapie Cellulaire, Tours, France
[12] Ctr Leon Berard, Hematol, Lyon, France
[13] Inst Curie, Biostatist Dept, St Cloud, France
[14] Inst Curie, Project Management, St Cloud, France
[15] Inst Curie, Data Management, St Cloud, France
[16] Inst Curie, Dept Clin Immunol, Paris, France
[17] Inst Curie, INSERM U 932, Paris, France
[18] Inst Curie, Dept Hematol, Hop Rene Huguenin, St Cloud, France
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.785.785
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
785
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network
    Choquet, Sylvain
    Houillier, Caroline
    Bijou, Fontanet
    Houot, Roch
    Boyle, Eileen
    Gressin, Remy
    Nicolas-Virelizier, Emmanuelle
    Barrie, Maryline
    Molucon-Chabrot, Cecile
    Blonski, Marie
    El Yamani, Abderrazak
    Lelez, Marie-Laure
    Clavert, Aline
    Coisy, Solene
    de la Bretonniere, Marjan Ertault
    Touitou, Valerie
    Cassoux, Nathalie
    Boussetta, Sami
    Broussais, Florence
    Gelas-Dore, Benedicte
    Barzic, Noelie
    Ghesquieres, Herve
    Hoang-Xuan, Khe
    Soussain, Carole
    BLOOD, 2016, 128 (22)
  • [2] Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
    Ghesquieres, H.
    Chevrier, M.
    Laadhari, M.
    Chinot, O.
    Choquet, S.
    Molucon-Chabrot, C.
    Beauchesne, P.
    Gressin, R.
    Morschhauser, F.
    Schmitt, A.
    Gyan, E.
    Hoang-Xuan, K.
    Nicolas-Virelizier, E.
    Cassoux, N.
    Touitou, V
    Le Garff-Tavernier, M.
    Savignoni, A.
    Turbiez, I
    Soumelis, V
    Houillier, C.
    Soussain, C.
    ANNALS OF ONCOLOGY, 2019, 30 (04) : 621 - 628
  • [3] RADIOMICS ANALYSIS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) - A LOC NETWORK STUDY
    Royer-Perron, L.
    Bruno, A.
    Daniau, M.
    Labreche, K.
    Mokhtari, K.
    Them, L. Nguyen
    Houillier, C.
    Soussain, C.
    Hoang-Xuan, K.
    Alentorn, A.
    NEURO-ONCOLOGY, 2016, 18 : 78 - 78
  • [4] Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study
    Caroline Houillier
    Hervé Ghesquières
    Cécile Chabrot
    Carole Soussain
    Guido Ahle
    Sylvain Choquet
    Emmanuelle Nicolas-Virelizier
    Jacques-Olivier Bay
    Jacques Vargaftig
    Claude Gaultier
    Valérie Touitou
    Nadine Martin-Duverneuil
    Nathalie Cassoux
    Magali Le Garff-Tavernier
    Myrto Costopoulos
    Pierre Faurie
    Khê Hoang-Xuan
    Journal of Neuro-Oncology, 2017, 133 : 315 - 320
  • [5] Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study
    Houillier, Caroline
    Ghesquieres, Herve
    Chabrot, Cecile
    Soussain, Carole
    Ahle, Guido
    Choquet, Sylvain
    Nicolas-Virelizier, Emmanuelle
    Bay, Jacques-Olivier
    Vargaftig, Jacques
    Gaultier, Claude
    Touitou, Valerie
    Martin-Duverneuil, Nadine
    Cassoux, Nathalie
    Le Garff-Tavernier, Magali
    Costopoulos, Myrto
    Faurie, Pierre
    Hoang-Xuan, Khe
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (02) : 315 - 320
  • [6] Phase II trial of temsirolimus for relapsed/refractory primary central nervous system lymphoma (PCNSL)
    Kiewe, P.
    Martus, P.
    Thiel, E.
    Grobosch, T.
    Schlegel, U.
    Herlinger, U.
    Dreyling, M.
    Schmidt, C.
    Korfel, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 268 - 268
  • [7] Phase I clinical trial on pomalidomide and dexamethasone in treating patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) or primary vitreoretinal lymphoma (PVRL).
    Tun, Han W.
    Johnston, Patrick B.
    Grommes, Christian
    Reeder, Craig B.
    Omuro, Antonio Marcilio Padula
    Menke, David M.
    Copland, John A.
    DeAngelis, Lisa Marie
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network
    Sylvain, Choquet
    Baron, Marine
    Lavaud, Anne
    Soussain, Carole
    Touitou, Valerie
    Fardeau, Christine
    Cassoux, Nathalie
    Le Garff-Tavernier, Magali
    Costopoulos, Mirto
    Houillier, Caroline
    Maloum, Karim
    Leblond, Veronique
    Gyan, Emmanuel
    Soubeyran, Pierre
    BLOOD, 2017, 130
  • [9] Very High Efficiency of ICE (Ifosfamide-Carboplatin-Etoposide) in Relapse/Refractory (R/R) Primary Central Nervous System (PCNSL) and Vitreo-Retinal (VRL) Non Hodgkin Lymphoma. a LOC Network Multicenter Retrospective Study on 58 Cases
    Choquet, Sylvain
    Grenier, Adrien
    Houillier, Caroline
    Soussain, Carole
    Moles, Marie Pierre
    Gastinne, Thomas
    Cassoux, Nathalie
    Beral, Helene Merle
    Weil, Damien Roos
    Leblond, Veronique
    Xuan, Khe Hoang
    BLOOD, 2015, 126 (23)
  • [10] A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Chukwueke, Ugonma
    Wright, Isobel
    Muzikansky, Alona
    Russ, Alyssa
    Fontana, Brittney
    Kats, Vanessa
    O'Donnell, Colin
    Scalfani, Renee
    Acevedo-Naranjo, Brenda
    Lee, Eudocia
    Castro, Luis Nicolas Gonzalez
    McFaline-Figueroa, Jose Ricardo
    Aquilanti, Elisa
    Youssef, Gilbert
    Beroukhim, Rameen
    Forst, Deborah
    Reardon, David
    Wen, Patrick
    Batchelor, Tracy
    Torres, Alexandra
    Stefanik, Jennifer
    Fisher, Jennifer
    Meredith, David
    Murakami, Mark
    Garcia, Yuri
    Shipp, Margaret
    Nayak, Lakshmi
    NEURO-ONCOLOGY, 2023, 25
12345